0001662579-23-000114.txt : 20231120
0001662579-23-000114.hdr.sgml : 20231120
20231120162134
ACCESSION NUMBER: 0001662579-23-000114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hughes Owen
CENTRAL INDEX KEY: 0001575933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 231423050
MAIL ADDRESS:
STREET 1: C/O RADIUS HEALTH, INC.
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wk-form4_1700515278.xml
FORM 4
X0508
4
2023-11-16
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001575933
Hughes Owen
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #120
WATERTOWN
MA
02472
1
0
0
0
0
Stock Option (Right to Buy)
1.82
2023-11-16
4
A
0
52000
0
A
2033-11-15
Common Stock
52000
52000
D
33% of the shares underlying this option shall vest and become exercisable on November 16, 2024, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Jolie M. Siegel, Attorney-in-Fact
2023-11-20